Gene · 8744
Papers3,166
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
961 to 980 of 3,166
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ferroptosis-Related Gene MT1G as a Novel Biomarker Correlated With Prognosis and Immune Infiltration in Colorectal Cancer. | Front Cell Dev Biol | 2022 | 35517502 | PubTator, text mining | PubMed |
| A NK Cell Odyssey: From Bench to Therapeutics Against Hematological Malignancies. | Front Immunol | 2022 | 35493522 | PubTator, text mining | PubMed |
| The Interplay Between Inflammation and Stromal Components in Pancreatic Cancer. | Front Immunol | 2022 | 35493517 | PubTator, text mining | PubMed |
| Identification of an autophagy-related gene signature for predicting prognosis and immune activity in pancreatic adenocarcinoma. | Sci Rep | 2022 | 35488119 | PubTator, text mining | PubMed |
| Evaluation of allogeneic and autologous membrane-bound IL-21-expanded NK cells for chronic lymphocytic leukemia therapy. | Blood Adv | 2022 | 35486482 | PubTator, text mining | PubMed |
| Epigenome-wide association study of bronchopulmonary dysplasia in preterm infants: results from the discovery-BPD program. | Clin Epigenetics | 2022 | 35484630 | PubTator, text mining | PubMed |
| Decitabine increases neoantigen and cancer testis antigen expression to enhance T-cell-mediated toxicity against glioblastoma. | Neuro Oncol | 2022 | 35468205 | PubTator, text mining | PubMed |
| Cryopreserved PM21-Particle-Expanded Natural Killer Cells Maintain Cytotoxicity and Effector Functions In Vitro and In Vivo. | Front Immunol | 2022 | 35464440 | PubTator, text mining | PubMed |
| Human iPSC-Derived Renal Cells Change Their Immunogenic Properties during Maturation: Implications for Regenerative Therapies. | Cells | 2022 | 35456007 | PubTator, text mining | PubMed |
| Transcriptomics of Acute DENV-Specific CD8+ T Cells Does Not Support Qualitative Differences as Drivers of Disease Severity. | Vaccines (Basel) | 2022 | 35455361 | PubTator, text mining | PubMed |
| The Impact of Different Cell Culture Mediums on CD8+ T Cells Expansion: A Bioinformatics Study. | Cell J | 2022 | 35451586 | PubTator, text mining | PubMed |
| Environmental induced transgenerational inheritance impacts systems epigenetics in disease etiology. | Sci Rep | 2022 | 35440735 | PubTator, text mining | PubMed |
| Cord Blood Natural Killer Cells Inhibit Sepsis Caused by Feces-Induced Acute Peritonitis via Increasing Endothelium Integrity. | Cell Transplant | 2022 | 35438589 | PubTator, text mining | PubMed |
| Immunotherapy by mesenchymal stromal cell delivery of oncolytic viruses for treating metastatic tumors. | Mol Ther Oncolytics | 2022 | 35434272 | PubTator, text mining | PubMed |
| Ferroptosis-Related Long Noncoding RNAs as Prognostic Marker for Colon Adenocarcinoma. | Appl Bionics Biomech | 2022 | 35432591 | PubTator, text mining | PubMed |
| Breast Density and Estradiol Are Major Determinants for Soluble TNF-TNF-R Proteins in vivo in Human Breast Tissue. | Front Immunol | 2022 | 35432372 | PubTator, text mining | PubMed |
| Bibliometric Analysis of Chimeric Antigen Receptor-Based Immunotherapy in Cancers From 2001 to 2021. | Front Immunol | 2022 | 35432345 | PubTator, text mining | PubMed |
| Tumor microenvironment-aware, single-transcriptome prediction of microsatellite instability in colorectal cancer using meta-analysis. | Sci Rep | 2022 | 35428835 | PubTator, text mining | PubMed |
| Phospholipid Scramblases: Role in Cancer Progression and Anticancer Therapeutics. | Front Genet | 2022 | 35422844 | PubTator, text mining | PubMed |
| SNCA correlates with immune infiltration and serves as a prognostic biomarker in lung adenocarcinoma. | BMC Cancer | 2022 | 35421944 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8744/papers?page=49